首页|诱导化疗周期数对局部晚期鼻咽癌患者生存结局的影响

诱导化疗周期数对局部晚期鼻咽癌患者生存结局的影响

扫码查看
目的:评估不同周期诱导化疗(IC)对局部晚期鼻咽癌(LA-NPC)患者的疗效.方法:回顾性分析武汉大学人民医院2016年1月—2021年8月接受IC联合同期放化疗(CCRT)治疗的LA-NPC患者,根据IC周期分为IC<3组和IC≥3组.用t检验和χ2检验分析组间差异,采用Kaplan-Meier法及log-rank检验比较两组的生存结局,单变量和多变量Cox回归模型以确定潜在的独立预测因素,并进行亚组分析来探讨补充辅助化疗(AC)能否提高IC联合CCRT治疗LA-NPC的疗效.结果:共纳入138例LA-NPC患者(IC<3组92例、IC≥3组46例).中位随访时间为31.2个月.IC<3组1、3年无远处转移生存率(DMFS)显著优于IC≥3组(分别为86.9%vs 74.6%和86.9%vs 64.5%,P<0.01).亚组分析结果显示,在IC<3组中,IC联合CCRT后序贯AC可进一步改善患者的DMFS(1年:94.4%vs 75.0%;3年:91.6%vs 70.0%,P<0.01).多因素分析显示IC周期为DMFS的独立影响因素.结论:IC周期是LA-NPC的独立预后因素,与≥3周期IC相比,接受<3周期的IC可减少远处转移的发生;当患者接受<3周期IC联合CCRT后序贯AC可进一步提高患者的DMFS.
Effect of the number of cycles of induction chemotherapy on survival outcomes in patients with locally advanced nasopharyngeal carcinoma
Objective:To evaluate the efficacy of different cycles of induction chemotherapy(IC)in patients with locoregionally advanced nasopharyngeal carcinoma(LA-NPC).Methods:We retrospectively an-alyzed LA-NPC patients treated with IC combined with concurrent chemoradiotherapy(CCRT)in Re-min Hospital of Wuhan University from January 2016 to August 2021.They were divided into the IC<3 group and IC≥3 group according to IC cycles.T-tests and χ2-tests were used to analyze the dif-ferences between groups,Kaplan-Meier and log-rank tests were adopted to compare the survival out-comes,univariate and multivariate Cox regression models were adopted to identify potential indepen-dent predictors,and subgroup analyses were used to investigate whether complementary adjuvant che-motherapy(AC)could improve the efficacy of IC combined with CCRT for LA-NPC.Results:A to-tal of 138 patients with LA-NPC were included(92 in the IC<3 group and 46 in the IC≥3 group).The median follow-up time was 31.2 months,and the 1-and 3-year distant metastasis-free survival(DMFS)rates were significantly higher in the IC<3 group than in the IC≥3 group(86.9%vs 74.6%and 86.9%vs 64.5%,respectively,P<0.01).Subgroup analysis showed that sequential AC after IC combined with CCRT further improved patients'DMFS in the IC<3 group(1 year:94.4%vs 75.0%;3 years:91.6%vs 70.0%,P<0.01).Multifactorial analysis showed that the IC cycle was an independent factor for DMFS.Conclusion:IC cycle is an independent prognostic factor for LA-NPC,and receiving<3 cycles IC reduces the incidence of distant metastases as compared with≥3 cycles IC;sequential AC further improves patients'DMFS when they receive<3 cycles IC com-bined with CCRT.

Locoregionally Advanced Nasopharyngeal CarcinomaInduction ChemotherapyCycle NumberAdjuvant ChemotherapySurvival

宁婷婷、胡钦勇、黄华玉、刘文敏、李倩

展开 >

武汉大学人民医院肿瘤中心 湖北 武汉 430060

局部晚期鼻咽癌 诱导化疗 周期数 辅助化疗 生存

国家自然科学基金资助项目

81670144

2024

武汉大学学报(医学版)
武汉大学

武汉大学学报(医学版)

CSTPCD
影响因子:0.959
ISSN:1671-8852
年,卷(期):2024.45(3)
  • 11